000 01411 a2200433 4500
005 20250512054007.0
264 0 _c19870403
008 198704s 0 0 eng d
022 _a0305-7453
024 7 _a10.1093/jac/18.supplement_e.115
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVerbist, L
245 0 0 _aPharmacokinetics and tolerance after repeated doses of imipenem/cilastatin in patients with severe renal failure.
_h[electronic resource]
260 _bThe Journal of antimicrobial chemotherapy
_cDec 1986
300 _a115-20 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCilastatin
650 0 4 _aCyclopropanes
_xadverse effects
650 0 4 _aDipeptidases
_xantagonists & inhibitors
650 0 4 _aFemale
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aImipenem
650 0 4 _aKidney Failure, Chronic
_xmetabolism
650 0 4 _aKinetics
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aThienamycins
_xadverse effects
700 1 _aVerpooten, G A
700 1 _aGiuliano, R A
700 1 _aDebroe, M E
700 1 _aBuntinx, A P
700 1 _aEntwistle, L A
700 1 _aJones, K H
773 0 _tThe Journal of antimicrobial chemotherapy
_gvol. 18 Suppl E
_gp. 115-20
856 4 0 _uhttps://doi.org/10.1093/jac/18.supplement_e.115
_zAvailable from publisher's website
999 _c3474913
_d3474913